AnaptysBio (ANAB) Proxy filing summary

Executive summary

• The annual meeting is scheduled for August 11, 2026, with voting on key proposals including director elections, auditor ratification, executive compensation, and an amendment to the equity incentive plan.

• Proxy materials are primarily distributed electronically to reduce environmental impact and costs, with options for paper copies upon request.

• Only shareholders of record as of June 22, 2026, are entitled to vote, with each share representing one vote.

Voting matters and shareholder proposals

• Four main proposals: election of two Class III directors for three-year terms, ratification of KPMG LLP as auditor for FY ending June 30, 2027, a non-binding advisory vote on executive compensation, and approval of an amendment to the 2017 Equity Incentive Plan.

• Board recommends voting FOR all proposals.

• Shareholders may submit proposals for the 2027 annual meeting between April 28 and May 28, 2027; proposals for inclusion in proxy materials are due by February 22, 2027.

Board of directors and corporate governance

• Board leadership is separated between CEO and Chairman roles; Oleg Nodelman will become Chairman after the meeting.

• Majority of directors are independent per Nasdaq and SEC rules.

• Board committees include audit, compensation, and nominating/governance, each with defined charters and independent membership.

• Board diversity and director qualifications are considered, though no formal diversity policy is adopted.

• Shareholders can communicate with the board via the Corporate Secretary.